13G Filing: Point72 Asset Management and Karyopharm Therapeutics Inc. (KPTI)

Page 3 of 11

Page 3 of 11 – SEC Filing

CUSIP No. 48576U106
13G
Page  3  of  11  Pages
1
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Point72 Capital Advisors, Inc.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐
(b) ☒
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH:
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
3,466,000 (see Item 4)
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
3,466,000 (see Item 4)
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,466,000 (see Item 4)
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 ☐
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.3% (see Item 4)
12
TYPE OF REPORTING PERSON*
CO
*SEE INSTRUCTION BEFORE FILLING OUT

Follow Karyopharm Therapeutics Inc. (NASDAQ:KPTI)









Page 3 of 11